1921
Volume 99, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

We describe the case of a patient with severe fever with thrombocytopenia syndrome (SFTS) complicated by SFTS-associated encephalopathy who was successfully treated with 4-day plasma exchange followed by two-time convalescent plasma therapy. During plasma exchange, the plasma cytokines interferon-α and inducible protein-10 gradually decreased without change of plasma viral load. However, plasma viral load gradually decreased after convalescent plasma therapy. This case provides important insights for understanding the mechanisms of experimental therapy in severely affected SFTS patients.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.17-0766
2018-10-01
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/6/tpmd170766.html?itemId=/content/journals/10.4269/ajtmh.17-0766&mimeType=html&fmt=ahah

References

  1. Yu XJ, 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 364: 15231532. [Google Scholar]
  2. Oh WS, 2017. Effect of early plasma exchange on survival in patients with severe fever with thrombocytopenia syndrome: a multicenter study. Yonsei Med J 58: 867871. [Google Scholar]
  3. Park SY, Choi WY, Chong YP, Park SW, Wang EB, Lee WJ, Jee Y, Kwon SW, Kim SH, , 2016. Use of plasma therapy for severe fever with thrombocytopenia syndrome encephalopathy. Emerg Infect Dis 22: 13061308. [Google Scholar]
  4. Kim UJ, Kim DM, Ahn JH, Kang SJ, Jang HC, Park KH, Jung SI, , 2016. Successful treatment of rapidly progressing severe fever with thrombocytopenia syndrome with neurological complications using intravenous immunoglobulin and corticosteroid. Antivir Ther 21: 637640. [Google Scholar]
  5. Winters JL, , 2012. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines. Hematology Am Soc Hematol Educ Program 2012: 712. [Google Scholar]
  6. Park SY, 2017. Severe fever with thrombocytopenia syndrome-associated encephalopathy/encephalitis. Clin Microbiol Infect 24: 432.e1432.e4. [Google Scholar]
  7. Kim WY, 2015. Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea. Clin Infect Dis 60: 16811683. [Google Scholar]
  8. Cui N, 2015. Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis. J Infect 70: 5259. [Google Scholar]
  9. Sun Y, 2012. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis 206: 10851094. [Google Scholar]
  10. Kawashima H, Togashi T, Yamanaka G, Nakajima M, Nagai M, Aritaki K, Kashiwagi Y, Takekuma K, Hoshika A, , 2005. Efficacy of plasma exchange and methylprednisolone pulse therapy on influenza-associated encephalopathy. J Infect 51: E53E56. [Google Scholar]
  11. Liu X, 2015. Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study. Ther Apher Dial 19: 178184. [Google Scholar]
  12. Zhou B, Zhong N, Guan Y, , 2007. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357: 14501451. [Google Scholar]
  13. van Griensven J, Ebola-Tx Consortium , 2016. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med 374: 3342. [Google Scholar]
  14. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR, Convalescent Plasma Study Group; , 2015. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211: 8090. [Google Scholar]
  15. Hung IF, 2011. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 52: 447456. [Google Scholar]
  16. Beigel JH, IRC002 Study Team , 2017. Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study. Lancet Respir Med 5: 500511. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.17-0766
Loading
/content/journals/10.4269/ajtmh.17-0766
Loading

Data & Media loading...

Supplemental files

  • Received : 01 Oct 2017
  • Accepted : 30 May 2018
  • Published online : 01 Oct 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error